Latest Research & Analysis

16-Nov-2015 - At present this report is posted in real-time for free (with registration).  Probes Reporter is in the process of converting to a paid subscription service.  You should expect both timing and access to our content that you enjoy today for free will gradually change....

12-Nov-2015 - Disclosure Insight™ reports provide commentary and analysis on public company interactions with investors and with the SEC.  They are heavily reliant on our expertise with using the Freedom of Information Act.  Probes Reporter is in the process of converting to a paid...

12-Nov-2015 - At present this report is posted in real-time for free (with registration).  Probes Reporter is in the process of converting to a paid subscription service.  You should expect both timing and access to our content that you enjoy today for free will gradually change....

23-Oct-2015 - Disclosure Insight™ reports provide commentary and analysis on public company interactions with investors and with the SEC.  Valeant Pharmaceuticals $VRX  $116.16  Expect an array of protracted, distracting, and expensive investigations.   As of 30-...

14-Oct-2015 - At present this report is posted in real-time for free (with registration).  Starting November 1st Probes Reporter will become a paid subscription service.  At that time you should expect both timing and access to our content that you enjoy today for free will...

13-Oct-2015 - Disclosure Insight™ reports provide commentary and analysis on public company interactions with investors and with the SEC.  Soon Probes Reporter will become a paid subscription service.  At that time you should expect both timing and access to our content that you enjoy...

9-Oct-2015 - At present this report is posted in real-time for free (with registration).  Starting November 1st Probes Reporter will become a paid subscription service.  At that time you should expect both timing and access to our content that you enjoy today for free will gradually...

7-Oct-2015 - Disclosure Insight™ reports provide commentary and analysis on public company interactions with investors and with the SEC.  Soon Probes Reporter will become a paid subscription service.  At that time you should expect both timing and access to our content that you enjoy...

Pages